Standard
NEO1/NEO-EXT studies : Safety and exploratory efficacy of repeat avalglucosidase alfa dosing after up to 6 years in late-onset Pompe disease (LOPD). / Schoser, B.; Barohn, R.; Byrne, B.; Goker-Alpan, O.; Kishnani, P.; Ladha, S.; Laforet, P.; Mengel, E.; Pena, L.; Sacconi, S.; Straub, V.; Trivedi, J.; Van Damme, P.; van der Ploeg, A.; Vissing, J.; Young, P.; Haack, K.; Ivanina, I.; Wang, Y.; Dimachkie, M.
I:
Neuromuscular Disorders, Bind 30, 10.2020, s. S49.
Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › fagfællebedømt
Harvard
Schoser, B, Barohn, R, Byrne, B, Goker-Alpan, O, Kishnani, P, Ladha, S, Laforet, P, Mengel, E, Pena, L, Sacconi, S, Straub, V, Trivedi, J, Van Damme, P, van der Ploeg, A
, Vissing, J, Young, P, Haack, K, Ivanina, I, Wang, Y & Dimachkie, M 2020, '
NEO1/NEO-EXT studies: Safety and exploratory efficacy of repeat avalglucosidase alfa dosing after up to 6 years in late-onset Pompe disease (LOPD)',
Neuromuscular Disorders, bind 30, s. S49.
https://doi.org/10.1016/j.nmd.2020.08.012APA
Schoser, B., Barohn, R., Byrne, B., Goker-Alpan, O., Kishnani, P., Ladha, S., Laforet, P., Mengel, E., Pena, L., Sacconi, S., Straub, V., Trivedi, J., Van Damme, P., van der Ploeg, A.
, Vissing, J., Young, P., Haack, K., Ivanina, I., Wang, Y., & Dimachkie, M. (2020).
NEO1/NEO-EXT studies: Safety and exploratory efficacy of repeat avalglucosidase alfa dosing after up to 6 years in late-onset Pompe disease (LOPD).
Neuromuscular Disorders,
30, S49.
https://doi.org/10.1016/j.nmd.2020.08.012Vancouver
Schoser B, Barohn R, Byrne B, Goker-Alpan O, Kishnani P, Ladha S o.a.
NEO1/NEO-EXT studies: Safety and exploratory efficacy of repeat avalglucosidase alfa dosing after up to 6 years in late-onset Pompe disease (LOPD).
Neuromuscular Disorders. 2020 okt.;30:S49.
https://doi.org/10.1016/j.nmd.2020.08.012Author
Schoser, B. ; Barohn, R. ; Byrne, B. ; Goker-Alpan, O. ; Kishnani, P. ; Ladha, S. ; Laforet, P. ; Mengel, E. ; Pena, L. ; Sacconi, S. ; Straub, V. ; Trivedi, J. ; Van Damme, P. ; van der Ploeg, A. ; Vissing, J. ; Young, P. ; Haack, K. ; Ivanina, I. ; Wang, Y. ; Dimachkie, M. / NEO1/NEO-EXT studies : Safety and exploratory efficacy of repeat avalglucosidase alfa dosing after up to 6 years in late-onset Pompe disease (LOPD). I: Neuromuscular Disorders. 2020 ; Bind 30. s. S49.
Bibtex
@article{5bc8fb93d89240709c92222a55c077e0,
title = "NEO1/NEO-EXT studies: Safety and exploratory efficacy of repeat avalglucosidase alfa dosing after up to 6 years in late-onset Pompe disease (LOPD)",
author = "B. Schoser and R. Barohn and B. Byrne and O. Goker-Alpan and P. Kishnani and S. Ladha and P. Laforet and E. Mengel and L. Pena and S. Sacconi and V. Straub and J. Trivedi and {Van Damme}, P. and {van der Ploeg}, A. and J. Vissing and P. Young and K. Haack and I. Ivanina and Y. Wang and M. Dimachkie",
year = "2020",
month = oct,
doi = "10.1016/j.nmd.2020.08.012",
language = "English",
volume = "30",
pages = "S49",
journal = "Journal of Neuromuscular Diseases",
issn = "0960-8966",
publisher = "Elsevier",
note = "25th International Congress of the World-Muscle-Society (WMS) ; Conference date: 28-09-2020 Through 02-10-2020",
}
RIS
TY - ABST
T1 - NEO1/NEO-EXT studies
T2 - 25th International Congress of the World-Muscle-Society (WMS)
AU - Schoser, B.
AU - Barohn, R.
AU - Byrne, B.
AU - Goker-Alpan, O.
AU - Kishnani, P.
AU - Ladha, S.
AU - Laforet, P.
AU - Mengel, E.
AU - Pena, L.
AU - Sacconi, S.
AU - Straub, V.
AU - Trivedi, J.
AU - Van Damme, P.
AU - van der Ploeg, A.
AU - Vissing, J.
AU - Young, P.
AU - Haack, K.
AU - Ivanina, I.
AU - Wang, Y.
AU - Dimachkie, M.
PY - 2020/10
Y1 - 2020/10
U2 - 10.1016/j.nmd.2020.08.012
DO - 10.1016/j.nmd.2020.08.012
M3 - Conference abstract in journal
VL - 30
SP - S49
JO - Journal of Neuromuscular Diseases
JF - Journal of Neuromuscular Diseases
SN - 0960-8966
Y2 - 28 September 2020 through 2 October 2020
ER -
